Microbiome disruption may link SARS-CoV-2 to long-term health issues

This narrative review explores how the intestinal microbiome interacts with SARS-CoV-2 infection. The authors discuss how the virus might cause intestinal dysbiosis and modify immune signaling. They also note that the microbiota-gut-brain axis could affect neuropsychiatric and metabolic complications. Because the study is a narrative review, it summarizes existing ideas rather than testing new treatments on people. No specific patient groups or sample sizes were reported in this source. The authors did not find safety data or adverse events because this was not a clinical trial. The main reason to be careful is that these are theoretical connections, not proven causes. Readers should understand that integrating microbiome research into pandemic preparedness is a suggestion for future planning. This approach fits within a One Health framework that connects human, animal, and environmental health. More research is needed before any specific advice can be given to patients.